agnis combi 50 mg + 1000 mg tabletki powlekane
belupo lijekovi i kozmetika d.d. - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 1000 mg
agnis combi 50 mg + 850 mg tabletki powlekane
belupo lijekovi i kozmetika d.d. - vildagliptinum + metformini hydrochloridum - tabletki powlekane - 50 mg + 850 mg
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - leki stosowane w cukrzycy - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 dla dostępnych danych o różnych kombinacjach).
melkart duo 50 mg + 850 mg tabletki powlekane
g.l. pharma gmbh - vildagliptinum + metforminum - tabletki powlekane - 50 mg + 850 mg
melkart duo 50 mg + 1000 mg tabletki powlekane
g.l. pharma gmbh - vildagliptinum + metforminum - tabletki powlekane - 50 mg + 1000 mg
saxotin 50 mg tabletki
sandoz gmbh - vildagliptinum - tabletki - 50 mg
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - вилдаглиптин, metformina chlorowodorek - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 dla dostępnych danych o różnych kombinacjach).
agnis 50 mg tabletki
belupo lijekovi i kozmetika d.d. - vildagliptinum - tabletki - 50 mg
viglita 50 mg tabletki
zentiva, k.s. - vildagliptinum - tabletki - 50 mg
pernuvi 50 mg tabletki
teva b.v. - vildagliptinum - tabletki - 50 mg